Skip to main content

Table 1

From: Celecoxib decreases prostaglandin E2concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer

 

Demographics

 
 

High Risk

Cancer

 

NAF(plasma)

NAF(plasma)

Samples

35(26)1

12(13)2

Age (years)

  

   Median

53(50.5)

59(58)

   Range

30–81(30–81)

35–77(35–77)

Premenopausal

14(11)

3(3)

Race

  

   White

34(25)

12(13)

   Black

0

0

   Asian

0

0

   American Indian

1(1)

0

Primary risk factors for enrollment

  

   Family history

17(17)

0

   Atypia

6(6)

0

   History of breast cancer

3(3)

0

   New contralateral breast cancer

9(0)

0

   New ipsilateral breast cancer

0

12(13)

Concomitant medications

  

   Vitamins

14(12)

3(3)

   Alternative therapies

7(4)

1(2)

  1. 1: NAF was collected from both breasts of nine women who had cancer diagnosed on one side. NAF from the incident breast was placed in the cancer group and from the contralateral breast in the high risk group. Plasma from these women are included only in the cancer group.
  2. 2: We were unable to collect NAF from one cancer subject at baseline.